Publication | Open Access
In Vivo Response to Methotrexate Forecasts Outcome of Acute Lymphoblastic Leukemia and Has a Distinct Gene Expression Profile
80
Citations
39
References
2008
Year
Total XV, Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia, http://www.ClinicalTrials.gov (NCT00137111); Total XIIIBH, Phase III Randomized Study of Antimetabolite-Based Induction plus High-Dose MTX Consolidation for Newly Diagnosed Pediatric Acute Lymphocytic Leukemia at Intermediate or High Risk of Treatment Failure (NCI-T93-0101D); Total XIIIBL, Phase III Randomized Study of Antimetabolite-Based Induction plus High-Dose MTX Consolidation for Newly Diagnosed Pediatric Acute Lymphocytic Leukemia at Lower Risk of Treatment Failure (NCI-T93-0103D).
| Year | Citations | |
|---|---|---|
1999 | 13.2K | |
2004 | 12.4K | |
1999 | 11.6K | |
2003 | 9.9K | |
2001 | 2K | |
1996 | 2K | |
2002 | 1.9K | |
2003 | 1.1K | |
2004 | 643 | |
2006 | 512 |
Page 1
Page 1